InsomniaDraft guidance advises new treatment optionThe National Institute for Health and Care Excellence (NICE) recommended daridorexant (Quviviq, Idorsia) as a new second line treatment option for long term insomnia.1 Draft guidance published on 15 September recommended the once nightly pill as an option if cognitive behavioural therapy for insomnia has not worked or is unavailable or unsuitable. Evidence submitted to NICE’s independent appraisal committee showed a reduction in insomnia when compared with placebo over 12 months. An estimated 20 000 people in England could receive the treatment in its first year.Patient deathsPolice expand hospital inquiry in BrightonA police investigation into possible criminal negligence at the Royal Sussex County Hospital in Brighton, UK, has extended its scope to cover a further year and include cases of serious harm as well as deaths. Sussex Police, investigating around 40 neurosurgery and general surgery deaths from 2015 to 2020, has confirmed that this will…
Source link
